These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 2820877)
21. Vasodilatation and inhibition of mediator release represent two distinct mechanisms for prostaglandin modulation of acute mast cell-dependent inflammation. Raud J Br J Pharmacol; 1990 Mar; 99(3):449-54. PubMed ID: 2158843 [TBL] [Abstract][Full Text] [Related]
22. Prostaglandin release but not superoxide production by rat Kupffer cells stimulated in vitro depends on Na+/H+ exchange. Dieter P; Schulze-Specking A; Karck U; Decker K Eur J Biochem; 1987 Dec; 170(1-2):201-6. PubMed ID: 2826152 [TBL] [Abstract][Full Text] [Related]
23. Prostaglandin E2, adenosine 3':5'-cyclic monophosphate and changes in endometrial vascular permeability in rat uteri sensitized for the decidual cell reaction. Kennedy TG Biol Reprod; 1983 Dec; 29(5):1069-76. PubMed ID: 6317067 [TBL] [Abstract][Full Text] [Related]
24. The local edemogenic effects of leukotriene C4 and prostaglandin E2 in rats. Gulati OP; Malmsten C; Ponard G; Gulati N Prostaglandins Leukot Med; 1983 Jan; 10(1):11-7. PubMed ID: 6572403 [TBL] [Abstract][Full Text] [Related]
25. Effects of analogues of prostaglandin E2 and F2 alpha on the decidual cell reaction in the rat. Kennedy TG; Doktorcik PE Prostaglandins; 1988 Feb; 35(2):207-19. PubMed ID: 3163155 [TBL] [Abstract][Full Text] [Related]
26. Nitric oxide synthase and cyclo-oxygenase pathways in the inflammatory response induced by zymosan in the rat air pouch. Payá M; García Pastor P; Coloma J; Alcaraz MJ Br J Pharmacol; 1997 Apr; 120(8):1445-52. PubMed ID: 9113364 [TBL] [Abstract][Full Text] [Related]
27. Characterization of the increase in vascular permeability induced by vascular permeability factor in vivo. Collins PD; Connolly DT; Williams TJ Br J Pharmacol; 1993 May; 109(1):195-9. PubMed ID: 7684302 [TBL] [Abstract][Full Text] [Related]
28. Effect of nonsteroidal anti-inflammatory agents on immune complex- and chemotactic factor-induced inflammation. Issekutz AC; Bhimji S Immunopharmacology; 1982 Jun; 4(3):253-66. PubMed ID: 7107229 [TBL] [Abstract][Full Text] [Related]
29. Polymorphonuclear leukocyte dysfunction syndrome in patients with increasing sepsis severity. Kaufmann I; Hoelzl A; Schliephake F; Hummel T; Chouker A; Peter K; Thiel M Shock; 2006 Sep; 26(3):254-61. PubMed ID: 16912650 [TBL] [Abstract][Full Text] [Related]
30. Anti-inflammatory properties of a novel wound healing and immunomodulating agent, tetrachlorodecaoxygen complex (TCDO). Tissot M; Roch-Arveiller M; Mathieu J; Giroud JP; Stahl KW Agents Actions; 1990 Nov; 31(3-4):368-74. PubMed ID: 1964762 [TBL] [Abstract][Full Text] [Related]
31. Studies on the effect of intralipid on human monocyte functions in vitro. Szeinberg A; Messer G; Davidsohn J; Levanon M; Passwell JH Isr J Med Sci; 1986 Nov; 22(11):791-6. PubMed ID: 3025131 [TBL] [Abstract][Full Text] [Related]
32. In vivo effects of prostaglandin E2 and arachidonic acid on phagocytosis of fluorescent methacrylate microbeads by rat peritoneal macrophages. Fernández-Repollet E; Mittler RS; Tiffany S; Schwartz A J Histochem Cytochem; 1982 May; 30(5):466-70. PubMed ID: 6804558 [TBL] [Abstract][Full Text] [Related]
33. Differential inhibition of prostaglandin and superoxide production by dexamethasone in primary cultures of rat Kupffer cells. Dieter P; Schulze-Specking A; Decker K Eur J Biochem; 1986 Sep; 159(3):451-7. PubMed ID: 3019694 [TBL] [Abstract][Full Text] [Related]
34. Endothelial cells inhibit receptor-mediated superoxide anion production by human polymorphonuclear leukocytes via a soluble inhibitor. Basford RE; Clark RL; Stiller RA; Kaplan SS; Kuhns DB; Rinaldo JE Am J Respir Cell Mol Biol; 1990 Mar; 2(3):235-43. PubMed ID: 2155631 [TBL] [Abstract][Full Text] [Related]
35. Effect of exogenous prostaglandin E2 and actinomycin D on plasma leakage induced by neutrophil-activating peptide-1/interleukin-8. Colditz IG Immunol Cell Biol; 1990 Dec; 68 ( Pt 6)():397-403. PubMed ID: 2097295 [TBL] [Abstract][Full Text] [Related]
36. Selective inhibition of polymorphonuclear leukocytes by immunosuppressive concentration of prostaglandin E2. Hong YS J Korean Med Sci; 1996 Feb; 11(1):8-16. PubMed ID: 8703375 [TBL] [Abstract][Full Text] [Related]
37. Failure of prostaglandin E2 and its 16,16-dimethyl analogue to prevent the gastric mucosal damage induced by Paf. Steel G; Wallace JL; Whittle BJ Br J Pharmacol; 1987 Feb; 90(2):365-71. PubMed ID: 3470106 [TBL] [Abstract][Full Text] [Related]
38. Inhibition of gastric acid secretion by intracerebroventricularly administered prostaglandin e2 in anaesthetized rats. Puurunen J Br J Pharmacol; 1983 Jan; 78(1):131-5. PubMed ID: 6337659 [TBL] [Abstract][Full Text] [Related]
39. Mechanism of ionophore A23187 induction of plasma protein leakage and of its inhibition by indomethacin. Thomas G Eur J Pharmacol; 1982 Jun; 81(1):35-42. PubMed ID: 6180911 [TBL] [Abstract][Full Text] [Related]
40. Anti-inflammatory effects of prostaglandin E1: in vivo modulation of the formyl peptide chemotactic receptor on the rat neutrophil. Fantone JC; Marasco WA; Elgas LJ; Ward PA J Immunol; 1983 Apr; 130(4):1495-7. PubMed ID: 6300229 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]